Interestingly, an SGRM has been reported to decrease the GR-mediated PCa cell proliferation and CRPC tumor growth and viability without inhibiting the activity of the AR (Kach et al. 2017). This evidence concerns the gene NR3C1 and posterior cortical atrophy.